This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Letter: cytokeratin‐18 as a biomarker of hepatocellular carcinoma regression after transarterial chemoembolization. Authors' reply. Issue 1 (2nd December 2016)
Record Type:
Journal Article
Title:
Letter: cytokeratin‐18 as a biomarker of hepatocellular carcinoma regression after transarterial chemoembolization. Authors' reply. Issue 1 (2nd December 2016)
Main Title:
Letter: cytokeratin‐18 as a biomarker of hepatocellular carcinoma regression after transarterial chemoembolization. Authors' reply
Abstract : Linked Content This article is linked to Bock et al and He et al papers. To view these articles visithttps://doi.org/10.1111/apt.13578 andhttps://doi.org/10.1111/apt.13820 .